MedPage Today on MSN
New Kink in the Link Between GLP-1 Drugs and Cognition
By extending survival, GLP-1 agents may expand the dementia risk period for diabetes patie ...
Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...
The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and ...
Roche and Zealand Pharma announced last month that their amylin analog petrelintide elicited a 9% placebo-controlled weight ...
Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.
4P004 is a GLP-1 analog specifically engineered for intra-articular administration in the knee. It is designed to leverage ...
The table below is a review of notable updates that occurred in March 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.
Tirzepatide significantly improves health-related quality of life and physical functioning compared with dulaglutide in ...
A physician examines whether the FDA's loosening of wellness peptide restrictions means these compounds are actually safe and ...
Zacks Investment Research on MSN
RHHBY's Q1 results hit by currency headwinds, sales up 6% at CER
Swiss pharma giant Roche Holding AG's RHHBY first-quarter 2026 results were affected by currency headwinds. Sales totaled $18 ...
India's drug discovery suffers from gaps in basic research and local data, hindering innovation in modern medicine.
A physician examines whether the FDA's loosening of wellness peptide restrictions means these compounds are actually safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results